J
Jonathan Yen
Researcher at St. Jude Children's Research Hospital
Publications - 31
Citations - 1750
Jonathan Yen is an academic researcher from St. Jude Children's Research Hospital. The author has contributed to research in topics: Stem cell & Haematopoiesis. The author has an hindex of 13, co-authored 22 publications receiving 1330 citations. Previous affiliations of Jonathan Yen include Novartis & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Butyrate Greatly Enhances Derivation of Human Induced Pluripotent Stem Cells by Promoting Epigenetic Remodeling and the Expression of Pluripotency-Associated Genes
Prashant Mali,Bin Kuan Chou,Jonathan Yen,Zhaohui Ye,Jizhong Zou,Sarah N. Dowey,Robert A. Brodsky,Joyce E. Ohm,Wayne Yu,Stephen B. Baylin,Kosuke Yusa,Allan Bradley,David J. Meyers,Chandrani Mukherjee,Philip A. Cole,Linzhao Cheng +15 more
TL;DR: It is reported here that butyrate, a naturally occurring fatty acid commonly used as a nutritional supplement and differentiation agent, greatly enhances the efficiency of induced pluripotent stem (iPS) cell derivation from human adult or fetal fibroblasts and provides an efficient method for reprograming various human adult somatic cells, including cells from patients that are more refractory to reprogramming.
Journal ArticleDOI
Generation of induced pluripotent stem cells in the absence of drug selection.
TL;DR: It is shown that n -myc can substitute for c-myc and that drug selection is dispensable for reprogramming of fibroblasts to pluripotent stem cells, and that the resulting induced pluripotency cells contribute extensively to teratomas and chimeras.
Journal ArticleDOI
Directed evolution of adenine base editors with increased activity and therapeutic application.
Nicole M. Gaudelli,Dieter K. Lam,Holly A. Rees,Noris M. Solá-Esteves,Luis A. Barrera,David A. Born,Aaron Edwards,Jason Michael Gehrke,Seung-Joo Lee,Alexander Liquori,Ryan Murray,Michael S. Packer,Conrad Rinaldi,Ian Slaymaker,Jonathan Yen,Lauren Young,Giuseppe Ciaramella +16 more
TL;DR: In primary human T cells, ABE8s achieve 98–99% target modification, which is maintained when multiplexed across three loci, and in human CD34 + cells, Abe8 can recreate a natural allele at the promoter of the γ-globin genes HBG1 and HBG2 with up to 60% efficiency.
Journal ArticleDOI
Selective in vivo metabolic cell-labeling-mediated cancer targeting
Hua Wang,Ruibo Wang,Kaimin Cai,Hua He,Yang Liu,Jonathan Yen,Zhiyu Wang,Ming Xu,Yiwen Sun,Xin Zhou,Qian Yin,Li Tang,Iwona T. Dobrucki,Lawrence W. Dobrucki,Eric J. Chaney,Stephen A. Boppart,Timothy M. Fan,Stéphane Lezmi,Xuesi Chen,Lichen Yin,Jianjun Cheng +20 more
TL;DR: This work inhibits the cell-labeling activity of tetraacetyl-N-azidoacetylmannosamine (Ac4ManAz) by converting its anomeric acetyl group to a caged ether bond that can be selectively cleaved by cancer-overexpressed enzymes and thus enables the overexpression of azido groups on the surface of cancer cells.
Journal ArticleDOI
Base editing of haematopoietic stem cells rescues sickle cell disease in mice.
Gregory A. Newby,Gregory A. Newby,Gregory A. Newby,Jonathan Yen,Kaitly J. Woodard,Thiyagaraj Mayuranathan,Cicera R. Lazzarotto,Yichao Li,Heather Sheppard-Tillman,Shaina N. Porter,Yu Yao,Kalin Mayberry,Kelcee A. Everette,Kelcee A. Everette,Kelcee A. Everette,Yoonjeong Jang,Christopher J. Podracky,Christopher J. Podracky,Christopher J. Podracky,Elizabeth Thaman,Christophe Lechauve,Akshay Sharma,Jordana M. Henderson,Michelle Richter,Michelle Richter,Michelle Richter,Kevin T. Zhao,Kevin T. Zhao,Kevin T. Zhao,Shannon M. Miller,Shannon M. Miller,Shannon M. Miller,Tina Wang,Tina Wang,Tina Wang,Luke W. Koblan,Luke W. Koblan,Luke W. Koblan,Anton P. McCaffrey,John F. Tisdale,Theodosia A. Kalfa,Theodosia A. Kalfa,Shondra M. Pruett-Miller,Shengdar Q. Tsai,Mitchell J. Weiss,David R. Liu,David R. Liu,David R. Liu +47 more
TL;DR: This article used ABE8e-NRCH to convert the β-globin allele (HBBS) into Makassar βglobin (HBBG), a non-pathogenic variant.